1
|
Ceci FM, Ferraguti G, Lucarelli M, Angeloni A, Bonci E, Petrella C, Francati S, Barbato C, Di Certo MG, Gabanella F, Gavaruzzi F, Mastroianni CM, Minni A, Greco A, Ralli M, Ceccanti M, Tarani L, Fiore M. Investigating Biomarkers for COVID-19 Morbidity and Mortality. Curr Top Med Chem 2023:CTMC-EPUB-129692. [PMID: 36815637 DOI: 10.2174/1568026623666230222094517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2022] [Revised: 11/29/2022] [Accepted: 12/16/2022] [Indexed: 02/24/2023]
Abstract
BACKGROUND AND OBJECTIVE This retrospective study aims to disclose further early parameters of COVID-19 morbidity and mortality. METHODS Three hundred and eighty-two COVID-19 patients, recruited between March and April 2020, were divided into three groups according to their outcome: (1) hospital ward group (patients who entered the hospital wards and survived); (2) intensive care unit (ICU) group (patients who attended the ICU and survived); (3) the deceased group (patients admitted to ICU with a fatal outcome). We investigated routine laboratory parameters such as albumin, glycemia, hemoglobin amylase, lipase, AST, ALT, GGT, LDH, CK, MGB, TnT-hs, IL-6, ferritin, CRP, PCT, WBC, RBC, PLT, PT, INR, APTT, FBG, and D-dimer. Blood withdrawal was carried out at the beginning of the hospitalization period. RESULTS ANOVA and ROC data evidenced that the concomitant presence of alterations in albumin, lipase, AST, ALT, LDH, MGB, CK, IL-6, ferritin in women, CRP and D-dimer is an early sign of fatal outcomes. CONCLUSION The present study confirms and extends the validity of routine laboratory biomarkers (i.e., lipase, AST, ALT, LDH, CK, IL-6, ferritin in women, CRP and D-dimer) as indicators of COVID-19 morbidity and mortality. Furthermore, the investigation suggests that both gross changes in albumin and MGB, markers of liver and heart damage, may early disclose COVID-19 fatal outcomes.
Collapse
Affiliation(s)
- Flavio Maria Ceci
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - Giampiero Ferraguti
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - Marco Lucarelli
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - Antonio Angeloni
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - Enea Bonci
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - Carla Petrella
- Institute of Biochemistry and Cell Biology (IBBC-CNR), Rome, Italy
| | - Silvia Francati
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | | | | | | | - Francesca Gavaruzzi
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
| | | | - Antonio Minni
- Department of Sensory Organs, Sapienza University of Rome, Rome, Italy
| | - Antonio Greco
- Department of Sensory Organs, Sapienza University of Rome, Rome, Italy
| | - Massimo Ralli
- Department of Sensory Organs, Sapienza University of Rome, Rome, Italy
| | - Mauro Ceccanti
- Società Italiana per il Trattamento dell'Alcolismo e le sue Complicanze (SITAC), Rome, Italy
| | - Luigi Tarani
- Department of Pediatrics, Sapienza University of Rome, Rome, Italy
| | - Marco Fiore
- Institute of Biochemistry and Cell Biology (IBBC-CNR), Rome, Italy
| |
Collapse
|
2
|
Sahoo D, Pattanaik SR, Kumar PR, Gandhi R. Role of Serum Irisin During Early Pregnancy to Predict The Development of Gestational Diabetes Mellitus at 24-28 Weeks of Pregnancy in high-risk patients. Indian J Endocrinol Metab 2022; 26:61-67. [PMID: 35662754 PMCID: PMC9162247 DOI: 10.4103/ijem.ijem_466_21] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 12/31/2021] [Accepted: 02/27/2022] [Indexed: 11/21/2022] Open
Abstract
AIMS The aim of this prospective study was to investigate the role of serum irisin during early pregnancy to predict the development of GDM at 24-28 weeks in high-risk patients. METHODOLOGY This study was conducted among the pregnant women attending the Department of Endocrinology and antenatal clinic of Department of Obstetrics and Gynecology of MKCG Medical College for a period of one year with at least one risk factor for the development of gestational diabetes mellitus (GDM). Blood samples were collected for measurement of fasting plasma glucose, serum insulin, serum irisin, lipids (TC, LDL, HDL, TG), and HbA1c. Oral glucose tolerance test was performed using 75 g of glucose during the first trimester and between 24-28 weeks of pregnancy. Patients were diagnosed as GDM based upon IADPSG criteria at 24-28 weeks. Serum irisin, glycemic parameters, and homeostatic model assessment of insulin resistance during first trimester were analyzed for predicting GDM between 24-28 weeks. RESULTS Sixty-five patients were included in the study, out of which 20 (30.8%) patients developed GDM and the rest 45 patients had normal glucose tolerance (NGT). The first trimester mean serum irisin concentration was significantly lower in women who later developed GDM compared with women who had NGT (111.65 ± 25.43 μg/L vs 185.89 ± 28.89 μg/L). Serum irisin concentration was the best predictor with an optimal threshold value of 149 μg/L, which had sensitivity, specificity, positive predictive value, and negative predictive value of 90%, 91.1%, 81.8%, 95.3%, respectively, for predicting GDM at 24-28 weeks of pregnancy. CONCLUSION We suggest the utility of serum irisin as an early biomarker to predict the development of GDM later in pregnancy in high-risk patients.
Collapse
Affiliation(s)
- Devadarshini Sahoo
- Department of Endocrinology, MKCG Medical College and Hospital, Odisha, India
| | | | - Padala Ravi Kumar
- Department of Endocrinology, MKCG Medical College and Hospital, Odisha, India
| | - Ronak Gandhi
- Department of Endocrinology, MKCG Medical College and Hospital, Odisha, India
| |
Collapse
|
3
|
Singh SR, Dhanasekara CS, Tello N, Southerland P, Alhaj Saleh A, Kesey J, Dissanaike S. Variations in insulin requirements can be an early indicator of sepsis in burn patients. Burns 2021; 48:111-117. [PMID: 33714643 DOI: 10.1016/j.burns.2021.02.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 01/20/2021] [Accepted: 02/22/2021] [Indexed: 11/02/2022]
Abstract
INTRODUCTION A >25% increase in daily insulin dosing is suggestive of possible sepsis in burn patients, however, no conclusive evidence is available regarding the time point at which insulin dosing begins to increase. The purpose of this study is to determine the exact time point at which the insulin requirement increases among non-diabetic burn patients with sepsis. METHODS A retrospective chart review in non-diabetic burn patients with ≥20% total body surface area burned (TBSA) during 2010-2018 who received a blood culture for suspected sepsis. Absolute insulin dosing at intervals (0, 24, 48, 72, and 96 h prior to blood culture) were Box-Cox transformed and compared vs.-96 h reference using mixed-effects models accounting for within-patient dependencies. RESULTS Fifty-eight patients (84% males, age 44 ± 17 years, TBSA% 49 ± 17.5) were included. When cube root of daily insulin dosing was regressed on each time point in a mixed-effects model, statistically significant increase in insulin dosing compared to baseline was observed for -48 (p = 0.018), -24 (p = 0.011), and 0 h (p = 0.008). CONCLUSION Daily insulin dosing increases 48 h prior to development of other clinical signs of sepsis and can be used as a sensitive early marker.
Collapse
Affiliation(s)
- Simran R Singh
- Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX, USA.
| | | | - Nadia Tello
- Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX, USA.
| | - Parker Southerland
- Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX, USA.
| | - Adel Alhaj Saleh
- Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX, USA.
| | - Jennifer Kesey
- Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX, USA.
| | - Sharmila Dissanaike
- Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX, USA.
| |
Collapse
|
4
|
Li J, Kobata K, Kamei Y, Okazaki Y, Nishihara M, Wada H, Tamai H, Funato M, Jenkin G. Nucleated red blood cell counts: an early predictor of brain injury and 2-year outcome in neonates with hypoxic-ischemic encephalopathy in the era of cooling-based treatment. Brain Dev 2014; 36:472-8. [PMID: 23860386 DOI: 10.1016/j.braindev.2013.06.012] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2013] [Revised: 06/18/2013] [Accepted: 06/19/2013] [Indexed: 11/18/2022]
Abstract
BACKGROUND Raised nucleated red blood cell (NRBC) counts in neonates may indicate in utero hypoxia and brain damage. OBJECTIVE The study aimed to examine the use of NRBC counts as a predictor of brain injury and neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy (HIE) treated under current cooling-based strategy. METHODS Forty-three neonates with asphyxia between 2004 and 2010 were retrospectively investigated. Twenty neonates with moderate/severe HIE underwent hypothermia (HT), and 23 with mild HIE were treated in normothermia (NT). Neonates were divided into groups according to the presence of cerebral parenchymal lesions on magnetic resonance imaging (MRI) at 2 weeks after birth. All patients were followed-up neurologically for ⩾ 24 months. NRBC counts during the first 3 days were compared between groups. RESULTS Eleven HT (HT-N) and 21 NT (NT-N) neonates had normal MRI, and 9 HT (HT-L) and 2 NT (NT-L) neonates had parenchymal lesions. NRBC counts, both absolute and /100 white blood cells (WBC) counts, during the first 3 days in HT-L and NT-L were significantly higher than those in HT-N and NT-N, particularly within 6 hours after birth (HT-N: 502 [0-3060]/mm(3) vs HT-L: 2765 [496-6192]; 0 [0-3417] vs NT-L: 4384 [3978-4789], median [range]). Neonates with /100 white blood cells ⩾ 6/mm(3) and absolute NRBC counts ⩾ 1324/mm(3) within 6 hours of birth had high risks of abnormal MRIs and 2-year outcomes. CONCLUSIONS NRBC counts can predict brain injury and neurological outcomes in cooled and non-cooled asphyxiated neonates.
Collapse
Affiliation(s)
- Jingang Li
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan; The Ritchie Centre, Monash Institute of Medical Research, Clayton, VIC, Australia.
| | - Keisuke Kobata
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Yoshiya Kamei
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Yoko Okazaki
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Masato Nishihara
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Hiroshi Wada
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Hiroshi Tamai
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Masahisa Funato
- Department of Pediatrics, Yodogawa Christian Hospital, Osaka, Japan
| | - Graham Jenkin
- The Ritchie Centre, Monash Institute of Medical Research, Clayton, VIC, Australia; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia
| |
Collapse
|